Argen-X (ARGX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.053x

Based on the latest financial reports, Argen-X (ARGX) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€386.77 Million ≈ $452.18 Million USD) by net assets (€7.32 Billion ≈ $8.56 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ARGX net asset quality score to measure how much of total assets are equity-financed.

Argen-X - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Argen-X's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ARGX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Argen-X Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Argen-X ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ferrovial SE NASDAQ:FER	0.024x
E.ON SE F:EOAA	0.141x
Cenovus Energy Inc TO:CVE	0.067x
China Molybdenum Co Ltd Class A SHG:603993	0.041x
Orange S.A. PA:ORA	0.212x
Targa Resources Inc NYSE:TRGP	0.211x
Adani Ports and Special Economic Zone Limited NSE:ADANIPORTS	0.096x
Roche Holding AG SW:RO	0.296x

Annual Cash Flow Conversion Efficiency for Argen-X (2011–2025)

The table below shows the annual cash flow conversion efficiency of Argen-X from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see ARGX market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€7.32 Billion ≈ $8.56 Billion	€882.43 Million ≈ $1.03 Billion	0.120x	+900.59%
2024-12-31	€5.50 Billion ≈ $6.43 Billion	€-82.75 Million ≈ $-96.74 Million	-0.015x	+85.33%
2023-12-31	€4.10 Billion ≈ $4.79 Billion	€-420.33 Million ≈ $-491.41 Million	-0.103x	+66.55%
2022-12-31	€2.81 Billion ≈ $3.29 Billion	€-862.81 Million ≈ $-1.01 Billion	-0.307x	-28.06%
2021-12-31	€2.53 Billion ≈ $2.96 Billion	€-606.81 Million ≈ $-709.43 Million	-0.239x	-0.60%
2020-12-31	€1.67 Billion ≈ $1.96 Billion	€-398.46 Million ≈ $-465.85 Million	-0.238x	-285.30%
2019-12-31	€1.18 Billion ≈ $1.38 Billion	€151.63 Million ≈ $177.27 Million	0.128x	+228.46%
2018-12-31	€615.87 Million ≈ $720.02 Million	€-61.59 Million ≈ $-72.00 Million	-0.100x	+5.62%
2017-12-31	€413.81 Million ≈ $483.79 Million	€-43.84 Million ≈ $-51.26 Million	-0.106x	-163.35%
2016-12-31	€66.65 Million ≈ $77.92 Million	€11.15 Million ≈ $13.03 Million	0.167x	+144.86%
2015-12-31	€40.76 Million ≈ $47.65 Million	€-15.19 Million ≈ $-17.76 Million	-0.373x	-256.64%
2014-12-31	€60.90 Million ≈ $71.20 Million	€-6.37 Million ≈ $-7.44 Million	-0.105x	+65.66%
2013-12-31	€29.97 Million ≈ $35.04 Million	€-9.12 Million ≈ $-10.66 Million	-0.304x	+54.29%
2012-12-31	€16.65 Million ≈ $19.47 Million	€-11.09 Million ≈ $-12.96 Million	-0.666x	-366.21%
2011-12-31	€27.90 Million ≈ $32.62 Million	€-3.98 Million ≈ $-4.66 Million	-0.143x	--

About Argen-X

BR:ARGX Belgium Biotechnology

Market Cap

$60.40 Billion

€51.67 Billion EUR

Market Cap Rank

#570 Global

#3 in Belgium

Share Price

€830.80

Change (1 day)

+0.68%

52-Week Range

€464.10 - €830.80

All Time High

€830.80